NEW YORK (GenomeWeb News) — Novartis has licensed Caliper Life Sciences’ intellectual property covering non-invasive optical imaging methods, Caliper said today.
 
Under the multi-year agreement, the drug maker will use Caliper’s Optical Imaging patent suite, which includes imaging systems, reagents, related applications, and methods and services, Caliper said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A company hopes to capture the genetic diversity in India to power tailored therapeutics, BBC News reports.

Researchers tie variants in seven genes to insomnia risk, Live Science reports.

The US Environmental Protection Agency has approved an RNAi-based insecticide, according to the Atlantic.

In PLOS this week: locus near OAS1 linked to Sjogren's syndrome, rotavirus reassortment events uncovered by sequencing, and more.